P/E của cổ phiếu IQV là bao nhiêu?

IQVIA HOLDINGS INC (IQV) hiện giao dịch ở mức P/E 28.06 lần.

ROE của cổ phiếu IQV là bao nhiêu?

IQVIA HOLDINGS INC có tỷ suất lợi nhuận trên vốn chủ sở hữu (ROE) 22.28%.

Tỷ suất cổ tức của IQV là bao nhiêu?

IQVIA HOLDINGS INC có tỷ suất cổ tức 0.00%.

Điểm chất lượng (Quality Score) của IQV là bao nhiêu?

AI của chúng tôi đánh giá chất lượng tài chính tổng thể của IQV ở mức 54/100, dựa trên khả năng sinh lời, tăng trưởng, nợ và độ ổn định lợi nhuận.

Bây giờ có nên mua cổ phiếu IQV không?

Điểm AI Timing của IQV là 91/100, thể hiện mức độ hấp dẫn tương đối của giá hiện tại theo tín hiệu kỹ thuật và momentum — nên cân nhắc cùng điểm chất lượng và kế hoạch đầu tư của bạn.

Cổ phiếu IQV thuộc ngành nào?

IQVIA HOLDINGS INC được xếp vào ngành Healthcare >> Diagnostics & Research trên sàn NYSE

Cổ phiếu IQV (NYSE) | IQVIA HOLDINGS INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-06-30)

IQV AI Analysis Summary

Our AI summary for IQV: IQVIA HOLDINGS INC (NYSE), Healthcare >> Diagnostics & Research sector. The stock currently trades at a P/E of 28.06, ROE of 22.28%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

IQV

IQVIA HOLDINGS INC

US:NYSE STOCK Healthcare >> Diagnostics & Research News 99

USD 235.02

-2.77 (-1.16%) Day Change

Watchlist Portfolio Compare Chart

28.06

P/E

2.59

D/E

22.3%

ROE

4.6%

ROA

0.00%

Div Yield

IQVIA HOLDINGS INC
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 235.02 Price -2.77 (-1.16%) Day Change	NEWS SCORE: 99

IQV Chất lượng tổng thể của cố phiếu Không tốt lắm ( Chất lượng = 54) nhưng Thời điểm mua ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: [-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt lắm , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng

51%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	1989
Magic Formula Rank by ROE	1989
Magic Formula Rank by ROIC	2122
Price	235.02
PBV / Sector	6.12 / -29.69
Earning Per Share	8.38

PE / Sector	28.06 / 48.18
PEG or PE/Growth / Sector	N/A / 1.64
Average 1M Daily Value	275.35 M GREAT
Average 1W Daily Value	529.15 M

Yếu tố Kỹ thuật

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	8.10 / 13.01
NPM Average (%) / Sector	8.40 / 7.90
NPM Change Average (%) / Sector	2.17 / -6.69
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	4.60 / 11.73
ROA Average (%) / Sector	4.73 / -87.10
ROA Change Average (%) / Sector	2.20 / 167.77
ROE (%) / Sector	22.28 / -89.83 GOOD
ROE Average (%) / Sector	21.39 / -2.30 GOOD
ROE Change Average (%) / Sector	4.55 / -47.20
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.18
Dividend Average (%) / Sector	N/A / 1.19
Dividend Change Average (%) / Sector	N/A / 4.52

Chi tiết đăng ký

Analyze Date	2026-08-01 08:00:02
Symbol	IQV
Name	IQVIA HOLDINGS INC
Sector	Healthcare >> Diagnostics & Research
Market	NYSE
Listed Shares	164.60 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	38,581.42 / 38,081.42

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 2400 Ellis Road, Durham, NC, United States, 27703

Phone: 919 998 2000

Website: https://www.iqvia.com

Employees: 93,000

Sector: Healthcare >> Diagnostics & Research

Description: IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with Kexing Biopharm Co., Ltd. for biosimilar development. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.